Amgen Expected to Plead Guilty in U.S. Case
Linkedin

Amgen Expected to Plead Guilty in U.S. Case

New York City : NY : USA | Dec 17, 2012 at 9:19 PM PST
Source: The New York Times
XX XX
Views: Pending
 
December 17, 2012 The biotechnology giant Amgen is expected to plead guilty Tuesday to illegally marketing its drugs, people close to the investigation said Monday. The United States attorney's office for the Eastern District of New York said in an advisory sent to the media on Monday that Amgen was... FULL ARTICLE AT The New York Times
1 of 1
JaMarcus Russell has pleaded not guilty to drug charges
JaMarcus Russell has pleaded not guilty to drug charges
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

News Stories

 
  • Amgen to pay $762M settlement over drug marketing

      Arizona Republic
    Amgen will pay $762 million to settle litigation that accuses the drugmaker of marketing the anemia drug Aranesp for unapproved uses. A law firm involved in the case says the Thousand Oaks, Calif., company will pay a $612 million civil settlement, $...
  • Amgen To Plead Guilty In Marketing Probe

      Pharmalot
    Amgen is expected to plead guilty today to a misbranding charge in connection with off-label marketing of medications, according to a media advisory from the US Attorney in Brooklyn, New York, and a source familiar with the proceedings. In addition,...

Images

 >
 

More From Allvoices



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.